V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity

Blood

Volumn 94, Issue 5, 1999, Pages 1738-1746

  Thompsett, Andrew R ^a   Ellison, David W ^a   Stevenson, Freda K ^a   Zhu, Delin ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN LYMPHOMA; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE SEQUENCE; GENETIC HETEROGENEITY; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN STRUCTURE; IMMUNOGLOBULIN VARIABLE REGION; LARGE CELL LYMPHOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 0033198629     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.5.1738.417k10_1738_1746     Document Type: Article

References (46)

1. Grant JW, Isaacson PG: Primary central nervous system lymphoma. Brain Pathol 2:97, 1992
2. van der Valk P: Central nervous system lymphomas. Curr Diagn Pathol 3:45, 1996
3. Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63:939, 1989
4. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O'Fallon JR, Kelly PJ, Jack CR Jr, O'Neill BP: Primary intracerebral malignant lymphoma: A clinicopathological study of 89 patients. J Neurosurg 82:558, 1995
5. Abrey L, DeAngelis L, Yahalom J: Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859, 1998
6. Schwechheimer K, Braus DF, Schwarzkopf G, Feller AC, Volk B, Muller-Hermelink HK: Polymorphous high-grade B cell lymphoma is the predominant type of spontaneous primary cerebral malignant lymphomas. Histological and immunomorphological evaluation of computed tomography-guided stereotactic brain biopsies. Am J Surg Pathol 18:931, 1994
7. Berek C: The development of B cells and the B-cell repertoire in the microenvironment of the germinal center. Immunol Rev 126:5, 1992
8. MacLennan IC: Germinal centers. Annu Rev Immunol 12:117, 1994
9. Stevenson F, Sahota S, Zhu D, Ottensmeier C, Chapman C, Oscier D, Hamblin T: Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes. Immunol Rev 162:247, 1998
10. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, Kuppers R: Somatic hypermutation in normal and transformed human B cells. Immunol Rev 162:261, 1998
11. Levy R, Levy S, Cleary ML, Carroll W, Kon S, Bird J, Sklar J: Somatic mutation in human B-cell tumors. Immunol Rev 96:43, 1987
12. Bahler DW, Levy R: Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc Natl Acad Sci USA 89:6770, 1992
13. Zelenetz AD, Chen TT, Levy R: Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 176:1137, 1992
14. Zhu D, Hawkins RE, Hamblin TJ, Stevenson FK: Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br J Haematol 86:505, 1994
15. Hsu FJ, Levy R: Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 86:3072, 1995
16. Ottensmeier CH, Thompsett AR, Zhu D, Wilkins BS, Sweetenham JW, Stevenson FK: Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 91:4292, 1998
17. Küppers R, Rajewsky K, Hansmann ML: Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol 27:1398, 1997
18. + diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 91:1145, 1998
19. Smith WJ, Garson JA, Bourne SP, Kemshead JT, Coakham HB: Immunoglobulin gene rearrangement and antigenic profile confirm B cell origin of primary cerebral lymphoma and indicate a mature phenotype. J Clin Pathol 41:128, 1988
20. Kumanishi T, Washiyama K, Nishiyama A, Abe S, Saito T, Ichikawa T: Primary malignant lymphoma of the brain: Demonstration of immunoglobulin gene rearrangements in four cases by the Southern blot hybridization technique. Acta Neuropathol (Berl) 79:23, 1989
21. Albrecht S, Bruner JM, Segall GK: Immunoglobulin heavy chain rearrangements in primary brain lymphomas. A study using PCR to amplify CDR-III. J Pathol 169:297, 1993
22. Ellison DW, Steart PV, Gatter KC, Weller RO: Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 21:352, 1995
23. Hawkins RE, Zhu D, Ovecka M, Winter G, Hamblin TJ, Long A, Stevenson FK: Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 83:3279, 1994
24. Cook GP, Tomlinson IM: The human immunoglobulin VH repertoire. Immunol Today 16:237, 1995
25. Chang B, Casali P: The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 15:367, 1994
26. Corbett SJ, Tomlinson IM, Sonnhammer ELL, Buck D, Winter G: Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol 270:587, 1997
27. Stevenson FK, Smith GJ, North J, Hamblin TJ, Glennie MJ: Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity. Br J Haematol 72:9, 1989
28. Schutte ME, van Es JH, Silberstein LE, Logtenberg T: VH4.21-encoded natural autoantibodies with anti-i specificity mirror those associated with cold hemagglutinin disease. J Immunol 151:6569, 1993
29. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson FK, Capra JD: VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 149:2337, 1992
30. Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, Silverman GJ: Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 78:2372, 1991
31. Funkhouser WK, Warnke RA: Preferential IgH V4-34 gene segment usage in particular subtypes of B-cell lymphoma detected by antibody 9G4. Hum Pathol 29:1317, 1998
32. Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, Gilden DH: Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 43:236, 1998
33. Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, Antel J: Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 102:1045, 1998
34. Chapman CJ, Mockridge CI, Hamblin TJ, Stevenson FK: Tracking of the V4-34 (VH4-21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hypermutation. Clin Exp Immunol 105:360, 1996
35. Dorner T, Brezinschek HP, Foster SJ, Brezinschek RI, Farner NL, Lipsky PE: Delineation of selective influences shaping the mutated expressed human Ig heavy chain repertoire. J Immunol 160:2831, 1998
36. Betz AG, Neuberger MS, Milstein C: Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today 14:405, 1993
37. Hashimoto S, Dono M, Wakai M, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Ferrarini M, Silver J, Chiorazzi N: Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med 181:1507, 1995
38. Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML: Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from hislological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962, 1994
39. Braeuninger A, Kuppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML: Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells [published erratum appears in Proc Natl Acad Sci USA 94:14211, 1997]. Proc Natl Acad Sci USA 94:9337, 1997
40. Wilson PC, de Bouteiller O, Liu YJ, Potter K, Banchereau J, Capra JD, Pascual V: Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med 187:59, 1998
41. Goossens T, Klein U, Kuppers R: Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci USA 95:2463, 1998
42. Denepoux S, Razanajaona D, Blanchard D, Meffre G, Capra JD, Banchereau J, Lebecque S: Induction of somatic mutation in a human B cell line in vitro. Immunity 6:35, 1997
43. Larocca LM, Capello D, Rinelli A, Non S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Cammilleri-Broet S, Raphael M, Carbone A, Gaidano G: The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92:1011, 1998
44. Matsumoto M, Lo SF, Carruthers CJ, Min J, Mariathasan S, Huang G, Plas DR, Martin SM, Geha RS, Nahm MH, Chaplin DD: Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature 382:462, 1996
45. Kato J, Motoyama N, Taniuchi I, Takeshita H, Toyoda M, Masuda K, Watanabe T: Affinity maturation in Lyn kinase-deficient mice with defective germinal center formation. J Immunol 160:4788, 1998
46. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C: Sequences of Proteins of Immunological Interest (ed 5). Bethesda, MD, US Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No. 91-3242, 1991